Loading
Latest filing published 24 Aug 2026 for OCULAR THERAPEUTIX, INC., €200k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 24 August 2026, Pravin Dugel disclosed a transaction of €200k in Ocular Therapeutix, Inc. No broader history exists yet. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration